Opinion

Video

Treatment Approaches For Patients With BRAF-Mutated Melanoma and Asymptomatic Brain Metastases

For patients with BRAF-mutated melanoma with asymptomatic brain metastases, immunotherapy, particularly the combination of ipilimumab and nivolumab, is the preferred treatment option due to its effectiveness and durability, as supported by the seven-year follow-up data from the CHECKMATE 204 trial.

Related Videos
Michael A. Postow, MD
Matthew P. Deek, MD
5 KOLs are featured in this series.
5 KOLs are featured in this series.